Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Eye prosthesis – Retina
Reexamination Certificate
2006-07-04
2006-07-04
Willse, David H. (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Eye prosthesis
Retina
C606S004000, C606S107000, C604S019000, C128S898000
Reexamination Certificate
active
07070619
ABSTRACT:
Improved ophthalmological surgical methods, systems and devices, employing a colorant.
REFERENCES:
patent: 5236417 (1993-08-01), Wallis
patent: 5279298 (1994-01-01), Flower
patent: 5377686 (1995-01-01), O'Rourke et al.
patent: 5569191 (1996-10-01), Meyer
patent: 5576013 (1996-11-01), Williams et al.
patent: 5804448 (1998-09-01), Wang et al.
patent: 6367480 (2002-04-01), Coroneo
patent: 6372449 (2002-04-01), Coroneo
patent: 6533769 (2003-03-01), Holmen
patent: 6692526 (2004-02-01), Snyder et al.
patent: 2002/0147464 (2002-10-01), Peyman
patent: WO 99/58159 (1999-11-01), None
patent: WO 99/58160 (1999-11-01), None
Burk, Scott E., MD, PhD, Snyder, Michael E., MD; Cionni, Robert J., MD; Osher, Robert H., MD, Journal of Cataract Refractive Surgery, vol. 25, No. 6, pp. 1-9 (Jun. 1999).
Kadonosono et al. Staining of inernal limiting membrane in mascular hole surgery Arch Opthalomology, 2000; 118: 1116-1118.
Descroches, G. Indocyanine Green Staining of the Internal Limiting Membrane. www.occojournal.com.2001.
Olsen TW, Sternberg P Jr, Capone A Jr, et al., “Macular Hole Surgery Using Thrombin-Activated Fibrinogen and Selective Removal of the Internal Limited Membrane,” Retina, vol. 18, No. 4, pp. 322-329, (1998).
Yoon HS, Brooks HL, Jr., Capone A Jr., et al., “Ultrastructural Features of Tissue Removed During Idiopathic Macular Hold Surgery,” Am J Ophthalmol, vol. 122, No. 1, pp. 67-75, (1996).
Maguire AM, Smiddy WE, Nanda SK et al., “Clinicopathologic Correlation of Recurrent Epiretinal Membranes After Previous Surgical Removal,” Retina, vol. 10, No. 3, pp. 213-222, (1990).
Hope-Ross M, Yannuzzi LA, Gragoudas ES, et al., “Adverse Reactions Due to Indocyanine Green,” Ophthalmology, vol. 101, No. 3, pp. 529-533, (1994).
Destro M, Puliafito CA, “Indocyanine Green Videoangiography of Choroidal Neovascularization,” Ophthalmology, vol. 96, No. 6, pp. 846-853, (1989).
Yannuzzi LA, Slakter JS, Sorenson JA et al., “Digital Indocyanine Green Videoangiography and Choridal Neovascularization,” Retina, vol. 12, No. 3, pp. 191-223, (1992).
Guyer DR, Puliafito CA, Mones JM, et al., “Digital Indocyanine-Green Angiography in Chorioretinal Disorders,” Ophthalmology, vol. 99, No. 2, pp. 287-291, (1992).
Ho AC, Yannuzzi LA, Guyer DR, et al., “Intraretinal Leakage of Indocyanine Green Dye,” Ophthalmology, vol. 101, No. 3, pp. 534-541, (1994).
Mcenerney JK, Peyman GA, “Indocyanine Green: A New Vital Stain for Use Before Penetrating Keratoplasty,” Arch Ophthalmol, vol. 96, pp. 1445-1447, (1978).
Horiguchi M, Miyake K, Ohta I, Ito Y, “Staining of the Lens Capsule for Circular Continuous Capsulorrheix in Eyes with White Cataract,” Arch Ophthalmol, vol. 116, p. 535-537, (1998).
Smiddy, WE (Discussion by)- Park DW, Sipperley JO, Sneed SR et al., “Macular Hole Surgery with Internal-Limiting Membrane Peeling and Intravitreous Air,” Ophthalmology, vol. 106, No. 7, pp. 1397-1398, (1999).
Erza E, Aylward WG, Gregor ZJ, “Membranectomy and Autologous Serum for the Retreatment of Full-Thickness Macular Holes,” Arch Ophthalmol, vol. 115, pp. 1276-1280, (1997).
Ferris JD, “Pathogenesis of Idiopathicmacular Holes,” Current Opin Ophthalmol, vol. 8, pp. 87-93, (1997).
Weingeist TA, Goldman EJ, Folk JC et al., “Terson's Syndrome. Clinicopathologic Correlations,” Ophthalomogy, vol. 93, No. 11, pp. 1435-1442, (1986).
Russell SR, Hageman GS, “Hemorrhagic Detachment of the Internal Limiting Membrane After Penetrating Ocular Injury,” Retina, vol. 12, No. 4, pp. 346-350, (1992).
Livingstone, BI, Bourke, RD, “A Retrospective Study of Macular Holes with Pars Plana Vitrectomy Aust NZ J Ophthalmol,” 1999; in press.
Lutty, GA., “The Acute Intravenous Toxicity of Biological Stains, Dyes and Other Fluorescent Substances,” Toxicol Appl Pharmacol, 44: 225-249 (1978).
Friedman, Scott M. and Margo, Curtis E., “Bilateral Subinternal Limiting Membrane Hemorrhage with Terson Syndrome,” Am. J. of Ophthalmology, vol. 124, No. 6, pp. 850-851 (1997).
Foos FY, “Vitreoretinal Juncture: Topographical Variations,” Invest Ophthalmol, vol. 11, pp. 801-808 (1972).
Russell SR, Shepherd JD, Hageman GS, “Distribution of Glycoconjugates in the Human Retinal Internal Limiting Membrane,” Invest Ophthalmol Vis. Sci., vol. 32, pp. 1986-1995 (1991).
Burk Scott E.
Cionni Robert J.
Snyder Michael E.
Blanco Javier G.
Dobrusin & Thennisch PC
Willse David H.
LandOfFree
Ophthalmological surgery colorant and delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmological surgery colorant and delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmological surgery colorant and delivery system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3576467